Skip to main content
Log in

Tumor host relations

VI. Is alpha-ketoglutarate a tumor marker? Association with tumor extent in humans-correlation with tumor size in rats

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

A 4-year survey is presented on the alpha-ketoglutarate (KG) values in whole blood of 200 patients with malignant neoplasms mainly of the gastroinstestinal tract and the female breast. A group of patients with benign surgical diseases served as control. KG showed an association with the extent of the primary tumor classified according to the TNM-scheme. The percentages of single values above the 2s-range of the control were as follows: T2:18%, T3: 41%, and T 4: 64%. The mean value of KG had highly significantly increased already in stage T 2 as compared to the control group. Rats bearing the Yoshida sarcoma showed a significant correlation between the tumor size and the daily excretion of KG into urine during the early stage of tumor growth. The results suggested that KG cannot be regarded as an early tumor marker in humans, but may be of some value as an aid for the differential diagnosis in advanced tumor stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bergmeyer HU, Bernt E (1974) α-Ketoglutarat, UV-spektroskopische Bestimmung. In: Bergmeyer HU (ed) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim, p 1624

    Google Scholar 

  • Binder M, Winter R (1973) Die Konzentration der α-Ketoglutarsäure in den verschiedenen Stadien des Collumcarcinoms. Arch Gynäk 215: 315–324

    Google Scholar 

  • Kronberger L, Fink E (1969) Die α-Ketoglutarsäure-Erhöhung im Vollblut und die Lokalisation bzw. Histologie maligner Tumoren. Med Klinik 64: 2292–2296

    Google Scholar 

  • Kronberger L, Fink E (1973) Die Nachbehandlung der radikal und palliativ operierten sowie inoperablen Krebskranken mit Aspartat. Krebsgeschehen 5: 97–103

    Google Scholar 

  • LaFerla L (1959) Ketoacids and lactic acid content in the blood of subjects affected by larynx cancer. Atti Accad Med Lombarda 14: 634–637

    Google Scholar 

  • Ohara H, Tanaka J, Anzai T, Wada T (1967) Treatment of cancer as viewed from changes of glycolytic metabolites and related enzyme activity. I. On changes of blood values of pyruvate, lactate, and α-ketoglutarate and of serum LDH-activity. Tumor Res 2: 137–150

    Google Scholar 

  • Schaur RJ, Schreibmayer W, Semmelrock H-J, Tillian HM, Schauenstein E (1979) Tumor host relations. III. Increase of α-ketoglutarate in whole blood and urine and hypoalbuminemia of rats bearing the solid rhabdomyosarcoma BA 1112 and the ascitic or solid forms of Walker carcinoma 256 and Yoshida sarcoma. J Cancer Res Clin Oncol 93: 293–300

    Google Scholar 

  • Schreibmayer W, Schaur RJ, Tillian HM, Schauenstein E, Hagmüller K (in press) Tumor host relations. IV. Tissue distribution of citric acid cycle intermediates and of glutamate in tumor-bearing rats. High level of α-ketoglutarate in solid Yoshida sarcomas. J Cancer Res Clin Oncol 97:137–144

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung, Vienna

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kronberger, L., Semmelrock, H.J., Schaur, R.J. et al. Tumor host relations. J Cancer Res Clin Oncol 97, 295–299 (1980). https://doi.org/10.1007/BF00405781

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00405781

Key words

Navigation